Audrey Hecht
About Audrey Hecht
Audrey Hecht is a Research Associate I at LifeMine Therapeutics, with a background in Biological Sciences from Cornell University. She has held various research positions at prestigious institutions, including Cornell University and Columbia University Medical Center.
Work at LifeMine Therapeutics
Audrey Hecht serves as a Research Associate I at LifeMine Therapeutics, a position she has held since 2021. In this role, she contributes to the company's research initiatives in the field of therapeutic development. LifeMine Therapeutics focuses on harnessing the potential of natural products to create innovative medicines. Hecht's responsibilities include conducting experiments, analyzing data, and collaborating with team members to advance research projects.
Education and Expertise
Audrey Hecht earned a Bachelor of Science degree in Biological Sciences from Cornell University, where she studied from 2015 to 2017. Her educational background provides her with a strong foundation in biological research and methodologies. This expertise is further complemented by her various research roles in academic and professional settings, allowing her to apply her knowledge in practical environments.
Background
Before joining LifeMine Therapeutics, Audrey Hecht gained extensive experience in research and analysis through various roles. She worked as a Research Assistant at Cornell University from 2016 to 2017 and as an Intern at Columbia University Medical Center in 2015. Additionally, she served as an Analyst at The Cornell Hedge Fund during her time at Cornell, which further developed her analytical skills.
Previous Work Experience
Audrey Hecht has held several positions that have contributed to her professional development. After her tenure at Cornell University, she worked as a Research Student at Columbia University Medical Center from 2013 to 2014. Following that, she joined Forrester, where she served as a Research Associate from 2018 to 2019 and later as a Senior Research Associate from 2019 to 2021. These roles provided her with valuable insights into research methodologies and data analysis.